Civic Intelligence

Cure First

EIN 45-4721229 • 501(c)3 • Seattle, WA

Profile

Cure first mission is to accelerate discovery of targeted and less toxic treatment for cancer using innovative technologies.

1920 38th Ave ESeattle, WA 98112

www.curefirst.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

98th percentile

6.53x

Higher debt load relative to assets than 98% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Liabilities / Revenue

98th percentile

5.78x

Higher debt load relative to revenue than 98% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Net Margin

3rd percentile

-1127%

Higher net margin than 3% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2023

Top Officer Pay

84th percentile

$0

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2022

Asset Growth

10th percentile

-93%

Faster asset growth than 10% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Revenue Growth

15th percentile

-56%

Faster revenue growth than 15% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Assets

Down

$4,745

Down $60,390 (-93%) from 2022

Liabilities

Flat

$31,000

Flat from 2022

Net Assets

-

No earlier filing loaded for comparison.

Revenue

Down

$5,359

Down $6,776 (-56%) from 2022

Expenses

Up

$65,749

Up $40,942 (+165%) from 2022

Net Income

Down

-$60,390

Down $47,718 (-377%) from 2022

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$100K$50K$0Assets 2013: $24,728Net Assets 2013: $24,7282013Assets 2015: $82,920Liabilities 2015: $4,387Net Assets 2015: $78,5332015Assets 2016: $35,722Net Assets 2016: $35,7222016Assets 2017: $53,926Liabilities 2017: $02017Assets 2018: $17,919Net Assets 2018: $17,9192018Assets 2019: $28,201Net Assets 2019: $28,2012019Assets 2020: $33,374Net Assets 2020: $33,3742020Assets 2021: $46,807Liabilities 2021: $02021Assets 2022: $65,135Liabilities 2022: $31,000Net Assets 2022: $34,1352022Assets 2023: $4,745Liabilities 2023: $31,0002023

Highlighted filing

2023

Assets$4,745
Liabilities$31,000
Net Assets-

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$100K$0-$100KRevenue 2013: $16,234Expenses 2013: $6,015Net Income 2013: $10,2192013Revenue 2015: $121,800Expenses 2015: $43,939Net Income 2015: $77,8612015Revenue 2016: $139,136Expenses 2016: $181,947Net Income 2016: -$42,8112016Revenue 2017: $147,311Expenses 2017: $129,107Net Income 2017: $18,2042017Revenue 2018: $55,303Expenses 2018: $91,310Net Income 2018: -$36,0072018Revenue 2019: $33,455Expenses 2019: $23,173Net Income 2019: $10,2822019Revenue 2020: $12,259Expenses 2020: $7,086Net Income 2020: $5,1732020Revenue 2021: $14,724Expenses 2021: $1,291Net Income 2021: $13,4332021Revenue 2022: $12,135Expenses 2022: $24,807Net Income 2022: -$12,6722022Revenue 2023: $5,359Expenses 2023: $65,749Net Income 2023: -$60,3902023

Highlighted filing

2023

Revenue$5,359
Expenses$65,749
Net Income-$60,390

Filings

Latest Detailed Filing

The latest 2023 filing currently has summary financial data only. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 15, 2023
Return Version
2022v5.0
Gross Receipts
$12,135
Mission and Program Overview

Mission

Cure first mission is to accelerate discovery of targeted and less toxic treatment for cancer using innovative technologies.

Program Services

DescriptionGrantsExpenses
CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.-$20,000
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
PAT GRAY PHDDirector-$0--
SANDI EVERLOVEDirector-$0--
CARLA GRANDORI MD PHDPresident-$0--
KAREN SPRATT PHDTreasurer-$0--
JEFF LEEMDSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Cure First
EIN
45-4721229
Phone
2063378298
Address
1920 38TH AVE E, SEATTLE, WA 98112

Signing Officer

Name
Carla Grandori Md Phd
Title
Director
Signed
2023-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Visse & Company CPAs
Address
610 Market Street Suite 200, Kirkland, WA 98033
Preparer
Michael a Visse
Phone
4254544880
Supplemental Narrative

Additional Explanations

Other Expenses.1

Research $20000

Other Expenses.2

WEBSITE EXP $2517

Other Expenses.3

Licenses, Taxes $165

Other Expenses.4

BANK CHARGE $25

Total Liabilities.1

LOAN PAYABLE - Beginning $0 LOAN PAYABLE - Ending $31000

Raw XML Appendix177 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CARLA GRANDORI MD PHD
IRS990EZ/BooksInCareOfDetail/PhoneNum04252708523
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01920 38TH AVE E
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd098112
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt046807
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt065135
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt012133
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-12672
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02100
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt046807
IRS990EZ/Form990TotalAssetsGrp/EOYAmt065135
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt012135
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt02
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt046807
IRS990EZ/NetAssetsOrFundBalancesEOYAmt034135
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt046807
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt034135
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt24.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0PAT GRAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1SANDI EVERLOVE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2CARLA GRANDORI MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3KAREN SPRATT PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4JEFF LEEMD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt022707
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt020000
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt031000
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt024807
IRS990EZ/TotalProgramServiceExpensesAmt020000
IRS990EZ/TotalRevenueAmt012135
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0CUREFIRST.ORG
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt012133
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt014722
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt012256
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt033450
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt041953
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0114514
IRS990ScheduleA/GovtFurnSrvcFcltsVl509Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt02
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt02
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt05
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt019
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt031
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt00
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/CurrentTaxYearMinus4YearsAmt013750
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt013750
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt02
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt02
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt05
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt019
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt031
IRS990ScheduleA/InvestmentIncomeCYPct00.00020
IRS990ScheduleA/InvestmentIncomePYPct00.00020
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99980
IRS990ScheduleA/PublicSupportPY509Pct00.99980
IRS990ScheduleA/PublicSupportTotal509Amt0128264
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt012133
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt014722
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt012256
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt033450
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt055703
IRS990ScheduleA/Total509Grp/TotalAmt0128264
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt012135
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt014724
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt012259
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt033455
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt055722
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0128295
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Research $20000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1WEBSITE EXP $2517
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Licenses, Taxes $165
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3BANK CHARGE $25
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4LOAN PAYABLE - Beginning $0 LOAN PAYABLE - Ending $31000
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Total Liabilities.1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/FederatedAssuranceLevelCd0FAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0CARLA GRANDORI MD PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Director
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CURE FIRST
ReturnHeader/Filer/BusinessNameControlTxt0CURE
ReturnHeader/Filer/EIN0454721229
ReturnHeader/Filer/PhoneNum02063378298
ReturnHeader/Filer/USAddress/AddressLine1Txt01920 38TH AVE E
ReturnHeader/Filer/USAddress/CityNm0SEATTLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0WA
ReturnHeader/Filer/USAddress/ZIPCd098112
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0542088418
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Visse & Company CPAs
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0610 Market Street Suite 200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Kirkland
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0WA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd098033
ReturnHeader/PreparerPersonGrp/PhoneNum04254544880
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MICHAEL A VISSE
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02023-11-15T13:46:06-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0CARLA GRANDORI MD
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0PHD
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits